An Industrial Platform Solution for Antibody Fragment PurificationBioProcess International
Structure of a typical full-size IgG antibody molecule showing its... | Download Scientific Diagram
Structure of antibody (A) and the antibody-binding proteins used in... | Download Scientific Diagram
Affinity chromatography resins - KANEKA KanCap™L
Fc‐fusion proteins: new developments and future perspectives | EMBO Molecular Medicine
Immunoglobulin structure and function
Affinity Chromatography Resins—Antibody Therapeutics | Thermo Fisher Scientific - US
Types of Multiple Myeloma | International Myeloma Foundation
Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors - Journal of Biological Chemistry
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
Fragment Crystallizable Region - an overview | ScienceDirect Topics
Full article: Comparing domain interactions within antibody Fabs with kappa and lambda light chains
Immunoglobulin G | Review | InvivoGen
Antibody Fragment Purification Platform
Antibody Structure and Antibody Fragments
Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus | Scientific Reports
Antibody Fragments | Absolute Antibody
Frontiers | Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics | Immunology
Immunoglobulin light chain - Wikipedia
Soluble Monomeric IgG1 Fc* - Journal of Biological Chemistry
Fc receptor - Wikipedia
Secondary Antibody Selection - Jackson ImmunoResearch
Design and Manufacture of therapeutic Fc-fusion proteinsBioProcess International
